Effects of systemic steroids in patients with severe community-acquired pneumonia

European Respiratory Journal

Volumn 30, Issue 5, 2007, Pages 951-956

  Garcia Vidal, C ^a,c   Calbo, E ^a   Pascual, V ^a   Ferrer, C ^a   Quintana, S ^b   Garau, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Community acquired pneumonia; Immune response; Immunomodulation; Mortality; Systemic steroids

Indexed keywords

ANTIBIOTIC AGENT; MEPREDNISONE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; STREPTOCOCCUS PNEUMONIAE;

AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN; TREATMENT OUTCOME;

EID: 38849127566     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00027607     Document Type: Article

References (29)

1. Statistical Abstract of the United States. 104th Edn. Washington DC, US Government Printing Office, 1984.
2. Almirall J, Bolibar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-763.
3. Evans GM, Gaisford WF. Treatment of pneumonia with 2-(p- aminobenzenesulphonamido) pyrine. Lancet 1938; 2: 14-19.
4. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteriemic pneumoccoccal pneumonia. Ann Intern Med 1964; 60: 759-770.
5. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995; 107: 1342-1349.
6. Monton C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999; 27: 1745-1753.
7. Fernandez-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003; 10: 813-820.
8. Fine MJ, Auble T, Yealy D, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
10. Lionakis M, Kontoyiannis D. Glucocorticoids and invasive fungal infections. Lancet 2003; 362: 1828-1838.
11. Agustí C, Torres A. [Inflammatory response in pneumonia: are glucocorticosteroids useful?] Arch Bronconeumol 2003; 39: 143-145.
12. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-141.
13. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
14. Ruiz De Ona JM, Gomez Fernandez M, Celdran J, Puente-Maestu L. [Pneumonia in the patient with chronic obstructive pulmonary disease. Levels of severity and risk classification.] Arch Bronconeumol 2003; 39: 101-105.
15. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006; 28: 346-351.
16. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low dose" hydrocortisone in septic shock: a double-blind randomized, placebo controlled crossover study. Am J Respir Crit Care Med 2003; 167: 512-520.
17. De Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators, Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
18. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171: 242-248.
19. Salluh J, Verdeal J, Mello G, et al. Cortisol levels in patients with severe community-acquired pneumonia. Intensive Care Med 2006; 32: 595-598.
20. Montón C, Ewing S, Torres A, et al. Role of glucocorticoids on inflammatory response in nonimmunocompromised patients with pneumonia: a pilot study. Eur Respir J 1999; 14: 218-220.
21. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150: 710-716.
22. Boutten A, Dehoux MS, Seta N, et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996; 153: 336-342.
23. Mullol J, Pujols L, Picado C. [Mechanisms of action of glucocorticoids. Application to the treatment of respiratory inflammation.] Arch Bronconeumol 1996; 32: 527-534.
24. Raño A, Agusti C, Sibila O, Torres A. Associated inflammatory response in pneumonia: role of adjunctive therapy with glucocorticoids. Curr Opin Infect Dis 2006; 19: 179-184.
25. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-873.
26. Hotchkiss R, Karl I. The pathopysiology and treatment of sepsis. N Engl J Med 2003; 243: 138-150.
27. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocorticol steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocorticol hormones. 11th Edn. In: Brunton LL, Lazo JS, Parker KL eds. Goodman and Gilman's: The Pharmacological Basis of Theraspeutics. New York, McGraw Hill: 2006; pp. 1587-1612.
28. Agustí C, Rañó A, Fiella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment. Chest 2003; 123: 488-498.
29. Calbo E, Ochoa de Echagüen A, Rodríguez-Carballeira M, Ferrer C, Garau J. [Hospital admission, duration of stay and mortality in community-acquired pneumonia in an acute care hospital. Correlation between a pneumonia prognosis index and conventional clinical criteria for assessing severity.] Enf Infecc Microbiol Clin 2004; 22: 64-69.